Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin IINovelty and Significance

Hypertension - United States
doi 10.1161/hypertensionaha.116.07620
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Αvβ1 Integrin as a Novel Therapeutic Target for Tissue Fibrosis

Annals of Translational Medicine
Medicine
2016English

GPR35 as a Novel Therapeutic Target

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

KCa3.1 Ion Channel: A Novel Therapeutic Target for Corneal Fibrosis

PLoS ONE
Multidisciplinary
2018English

Essential Role of Smad3 in Angiotensin II-Induced Vascular Fibrosis

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2006English

New Insights Into Mechanisms Associated With Angiotensin II–Induced Vascular Hypertrophy and Remodeling

Hypertension
Internal Medicine
2016English

Endoplasmic Reticulum Stress: A Novel Mechanism and Therapeutic Target for Cardiovascular Diseases

Acta Pharmacologica Sinica
MedicinePharmacology
2016English

RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer

AAPS Journal
Pharmaceutical Science
2016English

Placental Extract Suppresses Cardiac Hypertrophy and Fibrosis in an Angiotensin II-induced Cachexia Model in Mice

Heliyon
Multidisciplinary
2019English

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis

Frontiers in Pharmacology
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy